Deborah Mash

Q: What Schools Are Affiliated With Deborah Mash

Deborah Mash is affiliated with the following schools: Nova Southeastern University, Florida State University, Columbia University, University of Miami

Deborah Mash's AcademicInfluence.com Rankings

Deborah Mash

Medical

#221

World Rank

#333

Historical Rank

#103

USA Rank

Pharmacology

#127

World Rank

#160

Historical Rank

#29

USA Rank

medical Degrees

Deborah Mash

Philosophy

#4616

World Rank

#7202

Historical Rank

#1315

USA Rank

Logic

#4460

World Rank

#5756

Historical Rank

#796

USA Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Deborah Mash Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Deborah Carmen Mash is an American professor of neurology and of molecular and cellular pharmacology at the Leonard M. Miller School of Medicine, and director of the Brain Endowment Bank at the University of Miami. She is also the Chief Executive Officer and founder of DemeRx.

(See a Problem?)

Deborah Mash's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Genotype-Tissue Expression (GTEx) project (2013) (6030)
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans (2015) (3904)
Genetic effects on gene expression across human tissues (2017) (2841)
Genetic effects on gene expression across human tissues (2017) (2841)
Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) (1656)
Dynamics of Hippocampal Neurogenesis in Adult Humans (2013) (1605)
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. (1985) (706)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. (2003) (546)
Genetic variation in human NPY expression affects stress response and emotion (2008) (407)
A Genomic Pathway Approach to a Complex Disease: Axon Guidance and Parkinson Disease (2007) (367)
Immunocytochemical localization of the dopamine transporter in human brain (1999) (328)
Autoradiographic localization of M1 and M2 muscarine receptors in the rat brain (1986) (325)
Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease (2007) (324)
Cholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum (2004) (321)
Adaptive Increase in D3 Dopamine Receptors in the Brain Reward Circuits of Human Cocaine Fatalities (1996) (315)
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis (2012) (308)
Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related Dementias (2014) (295)
Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain (1986) (288)
Butyrylcholinesterase in the life cycle of amyloid plaques (1997) (287)
Characterization of l‐[3H]Nicotine Binding in Human Cerebral Cortex: Comparison Between Alzheimer's Disease and the Normal (1986) (282)
Cocaethylene: A Unique Cocaine Metabolite Displays High Affinity for the Dopamine Transporter (1991) (281)
Common variants at MS 4 A 4 / MS 4 A 6 E , CD 2 AP , CD 33 and EPHA 1 are associated with late-onset Alzheimer ’ s disease (2011) (274)
Lrrk2 and Lewy body disease (2006) (260)
Corrigendum: Synchronized age-related gene expression changes across multiple tissues in human and the link to complex diseases (2016) (242)
Cyanobacterial Blooms and the Occurrence of the neurotoxin beta-N-methylamino-L-alanine (BMAA) in South Florida Aquatic Food Webs. (2010) (231)
Differential Regulation of Molecular Subtypes of Muscarinic Receptors in Alzheimer's Disease (1995) (220)
Cocaethylene is more potent than cocaine in mediating lethality (1991) (215)
Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain (2003) (214)
Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain (2016) (212)
Substance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcohol (2011) (198)
The impact of rare variation on gene expression across tissues (2016) (197)
Immunochemical analysis of dopamine transporter protein in Parkinson's disease (1997) (197)
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2019) (194)
Beyond Guam: The cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases (2009) (189)
Differential cholinergic innervation within functional subdivisions of the human cerebral cortex: A choline acetyltransferase study (1992) (188)
Immunochemical Analysis of Vesicular Monoamine Transporter (VMAT2) Protein in Parkinson's Disease (1999) (183)
Synchronized age-related gene expression changes across multiple tissues in human and the link to complex diseases (2015) (167)
High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. (1994) (167)
Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. (1997) (161)
Localization of nerve growth factor receptors in the normal human brain and in Alzheimer's disease (1989) (160)
Enhancing GTEx by bridging the gaps between genotype, gene expression, and disease (2017) (158)
Dopamine transport function is elevated in cocaine users (2002) (156)
Loss of high‐affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: Implications for the failure of cholinergic replacement therapies (1991) (155)
Cholinergic innervation of the human striatum, globus pallidus, subthalamic nucleus, substantia nigra, and red nucleus (1992) (155)
Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons (1994) (153)
Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease (2013) (153)
Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics (2002) (145)
Cholinergic projections from the parabigeminal nucleus (Ch8) to the superior colliculus in the mouse: a combined analysis of horseradish peroxidase transport and choline acetyltransferase immunohistochemistry (1986) (145)
A Quantitative Proteome Map of the Human Body (2019) (143)
Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. (2014) (140)
Excited Delirium Syndrome (ExDS): defining based on a review of the literature. (2012) (139)
Downregulation of sodium channels during anoxia: a putative survival strategy of turtle brain. (1992) (134)
Intronic Polymorphisms Affecting Alternative Splicing of Human Dopamine D2 Receptor Are Associated with Cocaine Abuse (2011) (130)
Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics (2003) (130)
Fatal excited delirium following cocaine use: epidemiologic findings provide new evidence for mechanisms of cocaine toxicity. (1997) (124)
Visualizing Dopamine and Serotonin Transporters in the Human Brain with the Potent Cocaine Analogue [125I]RTI‐55: In Vitro Binding and Autoradiographic Characterization (1994) (122)
Ibogaine: Complex Pharmacokinetics, Concerns for Safety, and Preliminary Efficacy Measures (2000) (119)
Gene Expression in Human Hippocampus from Cocaine Abusers Identifies Genes which Regulate Extracellular Matrix Remodeling (2007) (113)
Cocaine-associated agitated delirium and the neuroleptic malignant syndrome. (1996) (113)
D3 Dopamine and Kappa Opioid Receptor Alterations in Human Brain of Cocaine‐overdose Victims (1999) (111)
Brain biomarkers for identifying excited delirium as a cause of sudden death. (2009) (111)
Molecular profiling of midbrain dopamine regions in cocaine overdose victims (2003) (110)
Cocaine Abusers Have an Overexpression of α-Synuclein in Dopamine Neurons (2003) (109)
Melatonin MT1 and MT2 receptor expression in Parkinson's disease. (2010) (109)
Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain (2003) (102)
Characterization and Distribution of Transferrin Receptors in the Rat Brain (1990) (102)
Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers (2002) (101)
Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin. (1995) (99)
Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. (1996) (98)
Cyanobacterial Neurotoxin β-N-Methylamino-L-alanine (BMAA) in Shark Fins (2012) (98)
Response of rats to low levels of sarin. (2002) (92)
Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations. (2006) (92)
GABAergic Gene Expression in Postmortem Hippocampus from Alcoholics and Cocaine Addicts; Corresponding Findings in Alcohol-Naïve P and NP Rats (2012) (91)
Robust single-cell DNA methylome profiling with snmC-seq2 (2018) (89)
MDMA self‐administration in rats: acquisition, progressive ratio responding and serotonin transporter binding (2007) (87)
Distinct kinetic binding propeties of N‐[3H]‐methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain (1993) (86)
Neurofibrillary tangles in cholinergic pedunculopontine neurons in Alzheimer's disease (1988) (86)
Somatic sensory projections to the pretectum in the cat (1978) (86)
κ2 Opioid Receptors in Limbic Areas of the Human Brain Are Upregulated by Cocaine in Fatal Overdose Victims (1997) (86)
Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT‐PCR (2003) (82)
Medication Development of Ibogaine as a Pharmacotherapy for Drug Dependence a (1998) (79)
Vitamin D receptor and Alzheimer's disease: a genetic and functional study (2012) (79)
Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases (2013) (79)
Distribution of muscarinic receptor subtypes within architectonic subregions of the primate cerebral cortex (1988) (78)
Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians (2013) (77)
Criteria for the Interpretation of Cocaine Levels in Human Biological Samples and Their Relation to the Cause of Death (2004) (74)
Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment (2008) (74)
The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients (2012) (72)
Psychotic symptoms in Parkinson's disease. From description to etiology. (2005) (72)
Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapies. (1995) (71)
Identifying Consensus Disease Pathways in Parkinson's Disease Using an Integrative Systems Biology Approach (2011) (71)
The natural non-protein amino acid N-β-methylamino-l-alanine (BMAA) is incorporated into protein during synthesis (2014) (70)
Prevalent polymorphism in thyroid hormone-activating enzyme leaves a genetic fingerprint that underlies associated clinical syndromes. (2015) (70)
Multiregional gene expression profiling identifies MRPS6 as a possible candidate gene for Parkinson's disease. (2006) (69)
Somatic mtDNA Mutation Spectra in the Aging Human Putamen (2013) (68)
Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons. (2003) (68)
Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine. (1989) (67)
Sigma receptors are associated with cortical limbic areas in the primate brain (1992) (67)
Causes of death in multiple system atrophy (2006) (67)
Nicotinic α5 receptor subunit mRNA expression is associated with distant 5′ upstream polymorphisms (2011) (65)
Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease (1993) (65)
Serotonin transporters upregulate with chronic cocaine use (2000) (64)
Cocaine‐induced alterations in nucleus accumbens ionotropic glutamate receptor subunits in human and non‐human primates (2005) (62)
Attenuation of muscarinic receptor-G-protein interaction in Alzheimer disease. (1995) (61)
Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene–gene–environment interaction (2013) (61)
Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson's disease (2001) (60)
Ibogaine in the treatment of heroin withdrawal. (2001) (59)
Cerebral uptake and protein incorporation of cyanobacterial toxin &bgr;-N-methylamino-L-alanine (2013) (59)
Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 5′ nuclease assay (2004) (58)
National Association of Medical Examiners position paper on the certification of cocaine-related deaths. (2004) (58)
Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum (2005) (57)
Integrated whole transcriptome and DNA methylation analysis identifies gene networks specific to late-onset Alzheimer's disease. (2015) (57)
Chapter 8 Ibogaine in the treatment of heroin withdrawal (2001) (57)
CYP3A5 Mediates Effects of Cocaine on Human Neocorticogenesis: Studies using an In Vitro 3D Self-Organized hPSC Model with a Single Cortex-Like Unit (2017) (56)
Expression of glutamatergic genes in healthy humans across 16 brain regions; altered expression in the hippocampus after chronic exposure to alcohol or cocaine (2014) (55)
Psychotic symptoms in Parkinson’s disease (2005) (55)
Population-scale tissue transcriptomics maps long non-coding RNAs to complex disease (2021) (54)
Frequency and type of electrocardiographic abnormalities in cocaine abusers (electrocardiogram in cocaine abuse). (1994) (54)
Altered dopamine transporter densities in alcohol‐preferring vervet monkeys (1996) (53)
Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice (1991) (52)
Phenotypic associations of tau and ApoE in Parkinson's disease (2007) (51)
Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach. (1994) (51)
Environmental neurotoxins β-N-methylamino-l-alanine (BMAA) and mercury in shark cartilage dietary supplements. (2014) (50)
Medication development of ibogaine as a pharmacotherapy for drug dependence. (1998) (50)
Common Human 5′ Dopamine Transporter (SLC6A3) Haplotypes Yield Varying Expression Levels In Vivo (2006) (50)
Localization of muscarinic receptor subtypes in brain stem areas regulating sleep. (1994) (49)
An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology (2012) (49)
PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease (2015) (48)
The serotonin agonist m-chlorophenylpiperazine (mCPP) binds to serotonin transporter sites in human brain. (1995) (48)
Glucocerebrosidase mutations in diffuse Lewy body disease. (2011) (46)
Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis (2000) (46)
FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expression (2009) (45)
Galanin: neurobiologic mechanisms and therapeutic potential for Alzheimer's disease. (2006) (44)
Species and cell-type properties of classically defined human and rodent neurons and glia (2017) (44)
Glucosidase-beta variations and Lewy body disorders. (2009) (43)
Inactivation of human immunodeficiency virus-1 at short time intervals using undiluted bleach. (1993) (42)
Effects of post-mortem delay on subunits of ionotropic glutamate receptors in human brain. (2000) (41)
A Common DIO2 Polymorphism and Alzheimer Disease Dementia in African and European Americans (2018) (41)
Natural History of Progressive Supranuclear Palsy: A Clinicopathologic Study from a Population of Brain Donors (2005) (40)
Noribogaine is a G-protein biased κ-opioid receptor agonist (2015) (40)
Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors. (1992) (40)
Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson's disease. (2001) (40)
Rarity of the Alzheimer disease-protective APP A673T variant in the United States. (2015) (39)
ATP13A2 variability in Parkinson disease (2009) (39)
An epigenome-wide association study of posttraumatic stress disorder in US veterans implicates several new DNA methylation loci (2020) (38)
Alzheimer disease (AD) specific transcription, DNA methylation and splicing in twenty AD associated loci (2015) (38)
Galanin receptor over-expression within the amygdala in early Alzheimer's disease: An in vitro autoradiographic analysis (2002) (38)
Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims (2007) (37)
Selective labeling and localization of the M4 (m4) muscarinic receptor subtype. (1994) (36)
Gene Network Dysregulation in Dorsolateral Prefrontal Cortex Neurons of Humans with Cocaine Use Disorder (2017) (36)
Correlating Human and Animal Studies of Cocaine Abuse and Gene Expression (2008) (36)
Genome-wide brain DNA methylation analysis suggests epigenetic reprogramming in Parkinson disease (2019) (36)
Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers (2017) (35)
The rhesus macaque is three times as diverse but more closely equivalent in damaging coding variation as compared to the human (2012) (35)
Adenosine A2A receptor mRNA expression in Parkinson's disease (2000) (34)
Cyanobacterial neurotoxin BMAA and brain pathology in stranded dolphins (2019) (34)
l-Serine Reduces Spinal Cord Pathology in a Vervet Model of Preclinical ALS/MND (2020) (34)
Response of F344 rats to inhalation of subclinical levels of sarin: exploring potential causes of Gulf War illness (2001) (34)
Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers (2005) (33)
Radioligand binding and immunoautoradiographic evidence for a lack of toxicity to dopaminergic nerve terminals in human cocaine overdose victims (1997) (33)
Thinning of the Arterial Media Layer as a Possible Preclinical Stage in HIV Vasculopathy: A Pilot Study (2012) (33)
Excited Delirium and Sudden Death: A Syndromal Disorder at the Extreme End of the Neuropsychiatric Continuum (2016) (33)
Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes (2018) (33)
Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers. (2008) (33)
Clinical heterogeneity of the LRRK2 G2019S mutation. (2006) (32)
Semi-quantitative reverse-transcriptase polymerase chain reaction: an approach for the measurement of target gene expression in human brain. (1999) (32)
Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP). (2005) (31)
DNA Methylation Dynamics and Cocaine in the Brain: Progress and Prospects (2017) (31)
Galanin Expression within the Basal Forebrain in Alzheimer's Disease: Comments on Therapeutic Potentiala (1998) (31)
Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine (1996) (31)
Cyanobacterial Neurotoxin BMAA and Mercury in Sharks (2016) (29)
The stuff that dreams are made of (2002) (28)
Quantitative PCR-based screening of α-synuclein multiplication in multiple system atrophy (2007) (27)
RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and alleles (2015) (27)
Insular pathology in Parkinson's disease patients with orthostatic hypotension. (2007) (27)
The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target (2018) (27)
Single nucleus multi-omics links human cortical cell regulatory genome diversity to disease risk variants (2019) (27)
Immunocytochemical demonstration of axonal and perikaryal acetylcholinesterase in human cerebral cortex (1991) (27)
RIG-1 receptor expression in the pathology of Alzheimer’s disease (2014) (26)
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
D3 receptor binding in human brain during cocaine overdose. (1997) (26)
Absence of C9ORF72 expanded or intermediate repeats in autopsy‐confirmed Parkinson's disease (2014) (25)
Spatial memory in aged rats is related to PKCγ-dependent G-protein coupling of the M1 receptor (2005) (25)
Human BDNF Isoforms are Differentially Expressed in Cocaine Addicts and are Sorted to the Regulated Secretory Pathway Independent of the Met66 Substitution (2008) (25)
Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration. (2015) (24)
Comparison of the concentration of messenger RNA encoding four muscarinic receptor subtypes in control and Alzheimer brains. (1992) (24)
Characterization and localization of galanin receptors in human entorhinal cortex (1998) (23)
Dopaminergic innervation of the human striatum in Parkinson's disease (2007) (23)
Altered Dopamine Synaptic Markers in Postmortem Brain of Obese Subjects (2017) (22)
Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy. (2007) (22)
Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy. (2017) (22)
Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics (2018) (21)
Dopamine transporter mRNA in autopsy studies of chronic cocaine users. (1999) (21)
Noribogaine stimulates naloxone‐sensitive [35S]GTPγS binding (1998) (20)
Circadian variations in radioligand binding to muscarine receptors in rat brain dependent upon endogenous agonist occupation (1985) (20)
Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy. (2015) (20)
The Dopamine Transporter in Human Brain (1997) (19)
Drug interactions with the dopamine transporter in cryopreserved human caudate. (2001) (19)
Ibogaine analogues. Synthesis and preliminary pharmacological evaluation of 7-heteroaryl-2-azabicyclo[2.2.2]oct-7-enes. (2003) (19)
Single nucleus multi-omics identifies human cortical cell regulatory genome diversity (2022) (18)
Motor fluctuations and dyskinesias in advanced/end stage Parkinson’s disease: a study from a population of brain donors (2007) (18)
First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models (2015) (16)
Oral noribogaine shows high brain uptake and anti-withdrawal effects not associated with place preference in rodents (2016) (16)
21‐Aminosteroids Interact with the Dopamine Transporter to Protect Against 1‐Methyl‐4‐Phenylpyridinium‐Induced Neurotoxicity (1992) (16)
[3H]-(+)-pentazocine binding to sigma recognition sites in human cerebellum. (1994) (16)
Characterization of kappa1-opioid receptor binding in human insular cortex. (1999) (15)
Are neuroadaptations in D3 dopamine receptors linked to the development of cocaine dependence? (1997) (15)
Assessment of the Association of D2 Dopamine Receptor Gene and Reported Allele Frequencies With Alcohol Use Disorders (2019) (15)
Do vervets and macaques respond differently to BMAA? (2016) (14)
Noribogaine reduces nicotine self-administration in rats (2015) (14)
Hallucinations in multiple system atrophy. (2007) (13)
Expression of alpha-synuclein mRNA in Parkinson's disease. (2007) (13)
Reduced LRRK 2 in association with retromer dysfunction in post-mortem brain tissue from LRRK 2 mutation carriers (2017) (13)
Correction: Somatic mtDNA Mutation Spectra in the Aging Human Putamen (2013) (13)
Cocaine promotes primary human astrocyte proliferation via JNK-dependent up-regulation of cyclin A2. (2016) (12)
Family history of dementia: dementia with lewy bodies and dementia in Parkinson's disease. (2006) (12)
BisQC: an operational pipeline for multiplexed bisulfite sequencing (2014) (10)
The Effect of Altered 5-Hydroxytryptamine Levels on β-Endorphin Content in Rat Brain (1986) (10)
Expression of α‐synuclein mRNA in Parkinson's disease (2007) (10)
Visual Hallucinations in Progressive Supranuclear Palsy (2006) (10)
EXCITATION study: Unexplained in-custody deaths: Evaluating biomarkers of stress and agitation. (2019) (9)
BMAA, Methylmercury, and Mechanisms of Neurodegeneration in Dolphins: A Natural Model of Toxin Exposure (2021) (9)
Reading LINEs within the cocaine addicted brain (2017) (9)
Cocaine-related DNA methylation in caudate neurons alters 3D chromatin structure of the IRXA gene cluster. (2020) (9)
Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional Consequences. (2019) (8)
Iron storage and transport markers in Parkinson’s disease and MPTP-treated mice (1993) (8)
CYANOBACTERIAL TOXINS IN NEURODEGENERATION (2008) (7)
Generation of disease-specific autopsy-confirmed iPSCs lines from postmortem isolated Peripheral Blood Mononuclear Cells (2017) (7)
Biochemical Brain Markers in Excited Delirium Deaths (2009) (7)
Breaking the cycle of opioid use disorder with Ibogaine. (2018) (6)
α‐synuclein aggregation and its relation to neurodegenerative diseases (2005) (6)
A Multicomponent Learning Model of Drug Abuse: Drug Taking and Craving May Involve Separate Brain Circuits Underlying Instrumental and Classical Conditioning, Respectively (1999) (6)
Does cigarette smoking provide clinically significant neuroprotection among patients diagnosed with Parkinson's disease? (2005) (6)
Clinical Addiction Psychiatry: Ibogaine therapy for substance abuse disorders (2010) (5)
Methylation of the tyrosine hydroxylase gene is dysregulated by cocaine dependence in the human striatum (2021) (5)
Making a family decision to donate the brain for genomic research: lessons from the genotype-tissue expression project (GTEx) (2021) (5)
Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90 (2022) (4)
A review of brain biorepository management and operations. (2018) (4)
Restriction Enzyme Based Enriched L1Hs Sequencing (REBELseq): A Scalable Technique for Detection of Ta Subfamily L1Hs in the Human Genome (2020) (4)
Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse (2021) (4)
Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones (2022) (4)
A preliminary report on the safety and pharmacokinetics of ibogaine (1995) (4)
The Dopamine Transporter in Human Brain Characterization and Effect of Cocaine Exposure (1996) (4)
CNVs in neurodevelopmental disorders (2015) (4)
Convergent abnormalities in striatal gene networks in human cocaine use disorder and mouse cocaine administration models (2023) (3)
Transferrin receptor regulation in Parkinson's disease and MPTP-treated mice. (1993) (3)
Hypothesizing Las Vegas and Sutherland Springs Mass Shooters Suffer from Reward Deficiency Syndrome: “Born Bad” (2017) (3)
Zhou et al. reply (2009) (3)
Disparities in death certificates of Parkinson's disease patients: A report from a population of brain donors (2006) (3)
Clinical Heterogeneity of the LRRK 2 G 2019 S Mutation (2006) (3)
Convergence of case-specific epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdose (2021) (3)
Dopamine transporter and receptor autoradiography in cocaine psychosis and sudden death (1995) (3)
Perinatal cocaine exposure alters sigma binding site density in the placenta (1993) (2)
The neurochemical mechanism of rebound psychosis in Parkinson's disease (2005) (2)
The influence of smoking, alcoholism and genetics on CYP2B6 in human brain (2003) (2)
Clinicopathologic Correlations in 172 Cases of REM Sleep Behavior Disorder ± a Coexisting Neurologic Disorder (PL01.003) (2013) (2)
GCH1 expression in human cerebellum from healthy individuals is not gender dependant (2009) (2)
Distinct kinetic binding properties of N-[3H]-methyl-scopolamine afford differential labeling and localization of M1, M2 and M3 muscarinic receptor subtypes (1993) (2)
Neuropsychiatric Consequences of Chronic Cocaine Abuse (2007) (2)
P1.217 Decreased putamen aldehyde dehydrogenase in Parkinson disease (2009) (1)
Vesicular monoamine transporter immunoreactivity is reduced in Parkinsons diseased striatum (1996) (1)
How to Test Antisense Oligonucleotides in Animals (1999) (1)
Corrigendum to "Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy" [Parkinsonism Relat. Disord. 35 (2017) 88-91]. (2017) (1)
BisQC: an operational pipeline for multiplexed bisulfite sequencing (2014) (1)
The rhesus macaque is three times as diverse but more closely equivalent in damaging coding variation as compared to the human (2012) (1)
In Vitro and In Vivo Imaging of the Human Dopamine Transporter in Cocaine Abusers (2002) (1)
Dopamine Receptor Diversity: Anatomy, Function, and Relevance to Parkinson's Disease (2003) (1)
Reply to Knuijver et al., on the "Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study". (2021) (1)
Whole transcriptome changes in the prefrontal cortex of late-onset Alzheimer's disease patients (2011) (1)
Altered SIRT4 Expression Is Associated with Lewy Body Pathology (P01.209) (2012) (1)
Muscarinic and Nicotinic Acetylcholine Receptors in the Hippocampal Formation of the Monkey (1987) (1)
Subject Index Vol. 54, 2005 (2006) (1)
Indole Alkaloids From Tissue-Cultured Tabernanthe Iboga H. Bn (1999) (1)
Roles of COMT, NPY and GCH1 in acute and chronic pain/stress response (2014) (1)
RNA transcription and editing in Alzheimer’s disease (2013) (1)
THE HUMAN BRAINOME: HUMAN BRAIN GENOME, TRANSCRIPTOME, AND PROTEOME INTEGRATION (2016) (1)
Role of RIG-1 signaling in the Pathogenesis of Alzheimer’s Disease (172.1) (2012) (1)
Cell type specific transcriptomic differences in depression show similar patterns between males and females but implicate distinct cell types and genes (2022) (0)
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) (0)
Biomarkers and mechanisms of central catecholamine deficiency in MSA (2015) (0)
Dopamine Transporter mRNA in Human Brain (2000) (0)
RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and alleles (2015) (0)
Large repeat expansions in the C9ORF72 gene contribute to a spectrum of neurodegenerative disorders including Alzheimer's disease in Caucasians, but not African-Americans (2012) (0)
Low dopamine D2 receptor expression drives gene networks related to GABA, cAMP, growth and neuroinflammation in striatal indirect pathway neurons (2022) (0)
The brain as an HIV-1 reservoir: Factors affecting HIV-1 infectivity (1993) (0)
Analysis of the Protective Effects of 21‐Aminosteroids in MPP+‐Induced Neurotoxicity to Dopaminergic Neurons in Mesencephalic Cultures a (1992) (0)
Modified Ibogaine Fragments: Synthesis and Preliminary Pharmacological Characterization of 3‐Ethyl‐5‐phenyl‐1,2,3,4,5,6‐hexahydroazepino[4,5‐b]benzothiophenes. (1999) (0)
Author response: Species and cell-type properties of classically defined human and rodent neurons and glia (2018) (0)
Semi-quantitative PCR based screening of α -Synuclein multiplication in multiple system atrophy (2008) (0)
Genome-wide analysis of DNA methylation differentiates late-onset Alzheimer's disease from dementia with Lewy bodies (2013) (0)
101 Assessment of Stress Markers in Restrained Individuals Following Physical Stress With and Without a Sham TASER Activation (2017) (0)
DNA Methylation of a Novel Regulatory Element Within the Tyrosine Hydroxylase Gene (TH) is Dysregulated by Chronic Cocaine Dependence in the Human Striatum (2021) (0)
Enhancing GTEx by bridging the gaps between genotype, gene expression, and disease (2017) (0)
Circadian variations in the binding of 3H-quinuclidinyl benzilate (QNB) to muscarine receptors (MR) in rat brain (1982) (0)
Robust single-cell DNA methylome profiling with snmC-seq2 (2018) (0)
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
Making a family decision to donate the brain for genomic research: lessons from the genotype-tissue expression project (GTEx) (2021) (0)
The natural non-protein amino acid N-β-methylamino-l-alanine (BMAA) is incorporated into protein during synthesis (2014) (0)
Gene Network Dysregulation in Dorsolateral Prefrontal Cortex Neurons of Humans with Cocaine Use Disorder (2017) (0)
Potential application of radiolabeled ligand studies of dementing diseases by positron emission tomography (1990) (0)
AGE RELATED CHANGES IN DOPAMINE TRANSPORTER IMMUNOREACTIVITY WITHIN THE HUMAN SUBSTANTIA NIGRA: AN UNBIASED STEREOLOGIC EVALUATION (1998) (0)
RIG-1 receptor expression in the pathology of Alzheimer’s disease (2014) (0)
A Unique Case of Cortical Myoclonus Sensitive to Visual Stimuli in the Peripersonal Space (2009) (0)
Contents Vol. 54, 2005 (2006) (0)
Cyanobacterial blooms and biomagnification of the neurotoxin BMAA in South Florida coastal waters (2008) (0)
13 Dopamine Receptor Diversity : Anatomy , Function , and Relevance to Parkinson ’ s Disease (2005) (0)
Single Nucleus Transcriptomics Reveals Pervasive Glial Activation in Opioid Overdose Cases (2023) (0)
Restriction Enzyme Based Enriched L1Hs sequencing (REBELseq) (2019) (0)
The effect of altered-hydroxytryptamine levels on beta endorphin content in rat brain (1981) (0)
Characterization of Noribogaine at nAChRs and Effect on Nicotine Self‐Administration in Rats (2015) (0)
Drug Development and Conservation in West and Central Africa/Performance of Neurochemical and Radio Receptor Assays of Plant Extracts (2002) (0)
Global assessment of non-coding RNA's regulation on altered transcription in the temporal pole of late-onset Alzheimer's disease patients (2012) (0)
Architecture Of Cholinergic Pre-And Postsynaptic Markers In The Primate Striatum (1988) (0)
Reply (1992) (0)
Decreased L-Aromatic-Amino-Acid Decarboxylase Activity and Vesicular Storage Contribute to Putamen Dopamine Depletion in Parkinson’s Disease and Multiple System Atrophy (P6.385) (2016) (0)
Abstracts of poster presentationsFurther characterization of the defect in M1 muscarinic receptor-G protein coupling in Alzheimer's disease (1993) (0)
Towards a clearer picture of somatic mitochondrial DNA mutation spectrums using next generation sequencing (2012) (0)
Heterozygote Dopamine Transporter Knockout Rats Display Enhanced Cocaine Locomotion in Adolescent Females (2022) (0)
Brain biomarkers of alcohol abuse at autopsy (2015) (0)
GENOME-WIDE METHYLATION CHANGES IN THE DORSAL MOTOR NUCLEUS OF THE VAGUS CONTRIBUTE TO THE RISK OF PARKINSON DISEASE (P1.106) (2017) (0)
Autoradiographic Localization Studies Of The Distribution Of M2 Receptors Suggest A Presynaptic Location On Cholinergic Tracts: Implications For Alzheimer's Disease (muscarinic, Autoreceptor) (1984) (0)
Noribogaine is a Mixed Agonist/Antagonist Opioid Ligand with Profound Functional Selectivity (2015) (0)
The effect of altered 5-hydroxytryptamine levels on beta-endorphin (1986) (0)
IUPHAR - invited review - Ibogaine - A legacy within the current renaissance of psychedelic therapy. (2023) (0)
Combining field, laboratory, and intervention strategies for HIV prevention (1993) (0)
Assessment of stress markers in restrained individuals following physical stress with and without sham CED activation. (2020) (0)
F269. Mitochondrial Transcriptome and Epigenetic Changes in the Human Hippocampus Chronically Exposed to Cocaine (2018) (0)
Drug Development and Conservation of Biodiversity in West and Central Africa: Performance of Neurochemical and Radio Receptor Assays of Plant Extracts Drug Discovery for the Central Nervous System (2004) (0)
Cyanobacteria, BMAA e ELA (2019) (0)
Association Studies of Neuropathologically-Confirmed Cases and Controls Reveals that the PARK10 Locus is a Major Contributor to Sporadic Parkinson disease. (S7.005) (2015) (0)

This paper list is powered by the following services:

Other Resources About Deborah Mash

What Schools Are Affiliated With Deborah Mash?

Deborah Mash is affiliated with the following schools:

Deborah Mash's Academic­Influence.com Rankings

Why Is Deborah Mash Influential?

Deborah Mash's Published Works

Published Works

Other Resources About Deborah Mash

What Schools Are Affiliated With Deborah Mash?

Deborah Mash's AcademicInfluence.com Rankings